8-K: Core Scientific Appoints Jim Nygaard as New CFO, Denise Sterling to Depart

Core Scientific announces the appointment of Jim Nygaard as its new CFO, effective March 17, 2025, succeeding Denise Sterling, who will depart on May 1, 2025, after playing a key role in the company's restructuring.

Summary

• Core Scientific has appointed James P. Nygaard, Jr. as Executive Vice President and Chief Financial Officer, effective March 17, 2025.
• Nygaard succeeds Denise Sterling, who will depart on May 1, 2025, after assisting with the transition.
• Nygaard brings nearly 30 years of investment banking experience, including M&A and corporate finance.
• He previously served as CFO of Power & Digital Infrastructure Acquisition Corp. (XPDI), which merged with Core Scientific.
• Nygaard's employment agreement includes a base salary of $600,000 and participation in an annual incentive plan with a target equal to 100% of his base salary.
• He will also receive an equity grant of 819,672 time-based restricted stock units.
• Denise Sterling played a critical role in stabilizing and repositioning Core Scientific through its Chapter 11 restructuring and helped raise over $1 billion through convertible note transactions.

Sentiment

Score: 7

Explanation: The document conveys a positive sentiment due to the planned and orderly CFO transition, the appointment of an experienced executive, and the recognition of the outgoing CFO's contributions. The forward-looking statements also contribute to the positive outlook.

Positives

• Core Scientific secures an experienced CFO in Jim Nygaard with nearly 30 years of investment banking and corporate finance experience.
• Nygaard's background includes M&A expertise, which could be beneficial for future strategic transactions.
• Denise Sterling successfully guided the company through a complex restructuring and secured significant capital, leaving the company well-positioned.
• The transition plan ensures a smooth handover of responsibilities with Sterling remaining until May 1, 2025.

Risks

• The success of Nygaard in his new role is dependent on his ability to adapt to the specific challenges and opportunities within Core Scientific.
• The departure of Denise Sterling, while planned, could create a temporary disruption as the company adjusts to new leadership in the finance department.
• The company's future performance is subject to risks outlined in its SEC filings, including those related to the strategic relationship with CoreWeave and other factors.

Future Outlook

The company expects that Jim Nygaard's expertise will help them continue scaling operations and drive growth and shareholder value. The company is also in the process of allocating and converting a significant portion of its nine operational data centers to support artificial intelligence-related workloads.

Management Comments

• Adam Sullivan, CEO of Core Scientific, stated that Jim Nygaard's deep background in corporate finance and M&A will help the company continue scaling its operations.
• Sullivan also noted that Nygaard's ability to drive growth and shareholder value will be an invaluable asset.
• Sullivan expressed gratitude for Denise Sterling's contributions, highlighting her role in navigating the restructuring and securing capital.

Industry Context

The appointment of a seasoned finance executive like Jim Nygaard signals Core Scientific's focus on strategic growth and financial stability as it navigates the evolving landscape of digital infrastructure for high-performance computing. The company's transition to AI-related workloads reflects a broader industry trend of leveraging HPC for advanced applications.

Comparison to Industry Standards

• Core Scientific's move to appoint a CFO with extensive M&A experience mirrors similar strategies employed by other companies in the tech and infrastructure sectors preparing for growth or potential consolidation.
• The compensation package for the new CFO, including base salary, incentives, and equity, appears to be in line with industry standards for executive roles in publicly traded companies of similar size and scope.
• Denise Sterling's success in raising over $1 billion through convertible notes is comparable to capital-raising efforts by other companies undergoing restructuring or seeking to fund expansion initiatives.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of an experienced CFO as a positive step towards financial stability and growth.
• Employees in the finance department will experience a change in leadership with the transition.
• The company's customers and partners may expect continued stability and reliability in financial operations.

Next Steps

• Jim Nygaard will assume his role as CFO on March 17, 2025.
• Denise Sterling will remain with the company until May 1, 2025, to ensure a smooth transition.
• The company will continue to execute its strategy of scaling operations and pursuing growth opportunities in the high-performance computing sector.

Key Dates

Keywords

CFO, Core Scientific, Nygaard, Sterling, Appointment, Finance, Restructuring, M&A, Executive, Chapter 11